Sling Therapeutics, Inc.
3 clinical trials · Sponsor
◉ Watch Sling Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED) (NCT07753603) | Sling Therapeutics, Inc. | 2026-08-04 |
| Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) (NCT06112340) | Sling Therapeutics, Inc. | 2023-10-11 |
| A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) (NCT05276063) | Sling Therapeutics, Inc. | 2022-07-01 |
Track Sling Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.